 |
市場調查報告書
商品編碼
1628089
心臟假體設備市場機會、成長動力、產業趨勢分析與預測 2025 - 2034 年Cardiac Prosthetic Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
||||||
2024 年，全球心臟假體器材市場價值為86 億美元，預計2025 年至2034 年複合年成長率為8.4%。老化的加劇。老年人更容易患心臟相關疾病，因此對這些設備產生了巨大的需求，特別是心臟瓣膜置換術和類似的干涉措施。
裝置材料、設計和微創植入技術的創新大大提高了心臟假體的安全性和效率。這些進步擴大了應用範圍，為無法接受傳統手術治療的患者帶來了更好的結果。心臟假體裝置是治療對藥物或微創解決方案無反應的嚴重心血管問題的關鍵工具。
該市場按產品分為起搏器和心臟瓣膜，其中起搏器將在 2024 年產生最高收入。無引線設計、MRI 相容性和無線連接等先進技術透過提高患者便利性和設備功能，進一步推動市場擴張。
| 市場範圍 | |
|---|---|
| 開始年份 | 2024年 |
| 預測年份 | 2025-2034 |
| 起始值 | 86 億美元 |
| 預測值 | 194 億美元 |
| 複合年成長率 | 8.4% |
就最終用途而言，市場分為醫院、門診手術中心和其他醫療機構。 2024 年，醫院在該領域佔據主導地位，預計到 2034 年將顯著成長，收入達到 90 億美元。醫院的專業心臟科室擴大配備先進設備來處理複雜的心臟手術，使這些設施成為心臟假體的最大消費者。此外，醫院正在優先考慮具有成本效益的解決方案，以提高患者的治療效果並縮短復原時間，從而進一步增加對創新心臟設備的需求。
從地理上看，北美在 2024 年將佔據 37 億美元的市場佔有率，並預計在預測期內以 7.7% 的複合年成長率大幅成長。心血管疾病的高盛行率，加上對技術創新的高度重視，使該地區成為關鍵市場。設備設計和微創手術的不斷進步正在推動醫療保健提供者的採用，確保更好的患者護理和結果。
目錄
第 1 章：方法與範圍
第 2 章：執行摘要
第 3 章：產業洞察
- 產業生態系統分析
- 產業影響力
- 成長動力
- 全球心血管疾病盛行率上升
- 心臟假體裝置的技術進步
- 老年族群對微創手術的偏好日益增加
- 提高對心臟病的認知和診斷
- 產業陷阱與挑戰
- 設備成本高
- 缺乏熟練的醫療保健專業人員
- 成長動力
- 成長潛力分析
- 監管環境
- 報銷場景
- 技術景觀
- 未來市場趨勢
- 差距分析
- 波特的分析
- PESTEL分析
第 4 章：競爭格局
- 介紹
- 公司矩陣分析
- 公司市佔率分析
- 主要市場參與者的競爭分析
- 競爭定位矩陣
- 戰略儀表板
第 5 章：市場估計與預測：按產品分類，2021 - 2034 年
- 主要趨勢
- 起搏器
- 植入式心律調節器
- 體外心律調節器
- 心臟瓣膜
- 機械心臟瓣膜
- 組織心臟瓣膜
- 經導管心臟瓣膜
第 6 章：市場估計與預測：依最終用途，2021 - 2034 年
- 主要趨勢
- 醫院
- 門診手術中心
- 其他最終用戶
第 7 章：市場估計與預測：按地區分類，2021 - 2034 年
- 主要趨勢
- 北美洲
- 美國
- 加拿大
- 歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
第 8 章：公司簡介
- Abbott Laboratories
- Abiomed
- AtriCure
- Biotronik
- Boston Scientific Corporation
- CryoLife
- Edwards Lifesciences Corporation
- Labcor Laboratorios
- Lepu Medical Technology
- Lifetech Scientific
- LivaNova
- Medtronic
- Meril Life Sciences
- MicroPort Scientific
- Siemens Healthcare
The Global Cardiac Prosthetic Devices Market was valued at USD 8.6 billion in 2024 and is projected to grow at a CAGR of 8.4% from 2025 to 2034. This growth is driven by advancements in medical technology, an increasing prevalence of cardiovascular conditions, a growing aging population, and a rising preference for minimally invasive procedures. The elderly, being more prone to heart-related conditions, are creating significant demand for these devices, particularly for heart valve replacements and similar interventions.
Innovations in device materials, design, and minimally invasive implantation techniques have greatly enhanced the safety and efficiency of cardiac prosthetics. These advancements have broadened the scope of applications, allowing for better outcomes for patients who cannot undergo traditional surgical treatments. Cardiac prosthetic devices are critical tools for managing severe cardiovascular issues that are unresponsive to medication or less invasive solutions.
The market is segmented by product into pacemakers and heart valves, with pacemakers generating the highest revenue in 2024. The rising prevalence of arrhythmias, including conditions that disrupt normal heart rhythm, is fueling demand for pacemakers. Advanced technologies like leadless designs, MRI compatibility, and wireless connectivity are further driving market expansion by improving patient convenience and device functionality.
| Market Scope | |
|---|---|
| Start Year | 2024 |
| Forecast Year | 2025-2034 |
| Start Value | $8.6 Billion |
| Forecast Value | $19.4 Billion |
| CAGR | 8.4% |
In terms of end-use, the market is categorized into hospitals, ambulatory surgical centers, and other healthcare settings. Hospitals dominated the segment in 2024 and are expected to see significant growth by 2034, reaching USD 9 billion in revenue. Specialized cardiac units in hospitals are increasingly equipped with advanced devices to handle complex cardiac procedures, making these facilities the largest consumers of cardiac prosthetics. Furthermore, hospitals are prioritizing cost-effective solutions that enhance patient outcomes and reduce recovery times, further boosting demand for innovative cardiac devices.
Geographically, North America accounted for USD 3.7 billion of the market share in 2024 and is poised for substantial growth at a CAGR of 7.7% during the forecast period. The high prevalence of cardiovascular diseases, coupled with a strong focus on technological innovation, positions this region as a key market. Continuous advancements in device design and minimally invasive procedures are driving adoption among healthcare providers, ensuring better patient care and outcomes.
Table of Contents
Chapter 1 Methodology and Scope
- 1.1 Market scope and definitions
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
- 1.4 Forecast model
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Increase in prevalence of cardiovascular diseases across the globe
- 3.2.1.2 Technological advancements in cardiac prosthetic devices
- 3.2.1.3 Increasing preferences for minimally invasive procedures among aging population
- 3.2.1.4 Rising awareness and diagnosis for cardiac ailments
- 3.2.2 Industry pitfalls and challenges
- 3.2.2.1 High cost of the devices
- 3.2.2.2 Dearth of skilled healthcare professionals
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.5 Reimbursement scenario
- 3.6 Technology landscape
- 3.7 Future market trends
- 3.8 Gap analysis
- 3.9 Porter's analysis
- 3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2024
- 4.1 Introduction
- 4.2 Company matrix analysis
- 4.3 Company market share analysis
- 4.4 Competitive analysis of major market players
- 4.5 Competitive positioning matrix
- 4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)
- 5.1 Key trends
- 5.2 Pacemaker
- 5.2.1 Implantable pacemaker
- 5.2.2 External pacemakers
- 5.3 Heart valves
- 5.3.1 Mechanical heart valve
- 5.3.2 Tissue heart valve
- 5.3.3 Transcatheter heart valve
Chapter 6 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)
- 6.1 Key trends
- 6.2 Hospitals
- 6.3 Ambulatory surgical centers
- 6.4 Other end users
Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)
- 7.1 Key trends
- 7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
- 7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Netherlands
- 7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
- 7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.6 Middle East and Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 UAE
Chapter 8 Company Profiles
- 8.1 Abbott Laboratories
- 8.2 Abiomed
- 8.3 AtriCure
- 8.4 Biotronik
- 8.5 Boston Scientific Corporation
- 8.6 CryoLife
- 8.7 Edwards Lifesciences Corporation
- 8.8 Labcor Laboratorios
- 8.9 Lepu Medical Technology
- 8.10 Lifetech Scientific
- 8.11 LivaNova
- 8.12 Medtronic
- 8.13 Meril Life Sciences
- 8.14 MicroPort Scientific
- 8.15 Siemens Healthcare
